The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Establishing Partnerships to Optimize Patient Outcomes
Establishing Partnerships to Optimize Patient Outcomes
Highlights from the MAGNIMS Consensus Guidelines
Highlights from the MAGNIMS Consensus Guidelines
Immunologic Effects on Metabolic Syndrome and MS
Immunologic Effects on Metabolic Syndrome and MS
Personalized Approach to Managing MS Patients - Dr. Andrew Chan
Personalized Approach to Managing MS Patients - Dr. Andrew Chan
Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh
Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh
Determining an MS Patient's Long-Term Prognosis
Determining an MS Patient's Long-Term Prognosis
The Value of Biomarkers in MS Patients
The Value of Biomarkers in MS Patients
